P757: Clinical utility of the 2021 ACMG gene tiers in expanded carrier screening*
Main Authors: | Dana Neitzel, Sarah Poll, Sienna Aguilar, Nicole Faulkner, Swaroop Aradhya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Genetics in Medicine Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774424008112 |
Similar Items
-
CHIMIA 2021, 75, 757
by: Werner Bonrath, et al.
Published: (2022-10-01) -
P681: Carrier screening with the ACMG 113: An early look and new insights
by: Vivienne Souter, et al.
Published: (2024-01-01) -
Expanding ACMG variant classification guidelines into a general framework
by: Emmanuelle Masson, et al.
Published: (2022-08-01) -
P672: Commercial cystic fibrosis carrier screening tests and coverage of the ACMG 100 recommended variants
by: Timothy Tidwell, et al.
Published: (2024-01-01) -
P682: ACMG ACT Sheets and Algorithms: Update process, development, and utilization
by: Molly Caisse, et al.
Published: (2023-01-01)